Abstract
Melanoma is a malignant tumour derived from melanocytes (dendritic cells originated from the neural crest and capable to produce melanin synthesis) that could be established on the skin or less frequently on the uvea. The cellular origin from both kind of melanoma seems to be the same but the melanocytes migrates to the epithelia for cutaneous melanoma, while for uveal melanoma, they migrate to mesodermic tissues. Despite the common origin, both melanomas show extreme differences in their metastatic potential, clinical response to treatments, immune response and genetic alterations. We will describe some of those differences in this review.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Geller AC, Swetter SM, Brooks K et al (2007) Screening, early detection, and trends for melanoma: current status (2000–2006) and future directions. J Am Acad Dermatol 57:555–576
Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE (2008) Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program. J Invest Dermatol 128:243–245
Singh AD, Bergman L, Seregard S (2005) Uveal melanoma: epidemiologic aspects. Ophthalmol Clin N Am 18:75–84
Singh AD, Topham A (2003) Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 110:956–961
Bergman L, Seregard S, Nilsson B et al (2002) Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 43:2579–2583
Shields JA (1973) Lesions simulating malignant melanoma of the posterior uvea. Arch Ophthalmol 89:466–471
Collaborative Ocular Melanoma Study Group (1990) Accuracy of diagnosis of choroidal melanomas in the COMS. COMS report no. 1. Arch Ophthalmol 108:1268–1273
Bell DJ, Wilson MW (2004) Choroidal melanoma: natural history and management options. Cancer Control 5:296–301
Damato B (2004) Developments in the management of uveal melanoma. Clin Exp Opthalmol 32:639–647
COMS (2001) Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 119:670–676
Shields JA, Shields CL, Donoso LA (1991) Management of posterior uveal melanoma. Surv Ophthalmol 36:161–195
Callejo SA, Antecka E, Blanco PL et al (2007) Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye 21:752–759
De Croock L, Verbraeken H (2002) Metastatic uveal melanoma: diagnosis and treatment: a literature review. Bull Soc Belge Ophtalmol 286:59–63
Diener-West M, Reynolds SM, Agugliaro DJ et al (2004) Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol 22:2438–2444
García-Alvarez C, Saornil MA, Muñoz F et al (2007) Ocular conservation in 273 patients with uveal melanoma by a multimodality approach. European Association for Vision and Eye Research annual meeting. Abstract book:39
Saornil MA, García-Alvarez C, Almaraz A et al (2007) Iodine-125 episcleral brachytherapy for uveal melanoma: 102 cases. Assessment. International Society of Ocular Oncology Meeting. Abstract book:333
Virgili G, Gatta G, Ciccolallo L et al; EUROCARE Working Group (2007) Incidence of uveal melanoma in Europe. Ophthalmology 114:2309–2315
Situm M, Buljan M, Buliæ SO, Simiæ D (2007) The mechanisms of UV radiation in the development of malignant melanoma. Coll Antropol 31:13–16
Singh AD, Rennie IG, Seregard S et al (2004) Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 49:419–428
Wilson YM, Richards KL, Ford-Perriss ML et al (2004) Neural crest cell lineage segregation in the mouse neural tube. Development 131:6153–6162
Lwigale PY, Conrad GW, Bronner-Fraser M (2004) Graded potential of neural crest to form cornea, sensory neurons and cartilage along the rostrocaudal axis. Development 131:1979–1991
Neale MH, Myatt NE, Khoury GG et al (2001) Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Res 11:601–609
Iwamoto S, Burrows RC, Kalina RE et al (2002) Immunophenotypic differences between uveal and cutaneous melanomas. Arch Ophthalmol 120:466–470
Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737
Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988
Singh SK HC, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:393–401
Perryman SV, Sylvester KG. (2006) Repair and regeneration: opportunities for carcinogenesis from tissue stem cells. J Cell Mol Med 10(2):292–308. Review
Borue X, Lee S, Grove J et al (2004) Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 165:1767–1772Borue X, Lee S, Grove J et al (2004) Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 165:1767–1772
Houghton J, Stoicov C, Nomura S et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568–1571
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
Yoshida H, Kunisada T, Grimm T et al (2001) Melanocyte migration and survival controlled by SCF/c-kit expression. J Invest Dermatol Symp Proc 6:1–5
Yanagisawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Dupin E, Le Dourain NM (2003) Development of melanocyte precursors from the vertebrate neural crest. Oncogene 22:3016–3023
Dorski RI, Daible DW, Moon RT (2000) Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 14:158–162
Dorsky RI, Moon RT, Raible DV (1998) Control of neural crest cell fate by the Wnt signalling pathway. Nature 396:370–373
Fang D, Leishear K, Nguyen TK et al (2006) Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells 24:1668–1677
Lee JT, Herlyn M (2007) Microenvironmental influences in melanoma progression. J Cell Biochem 101:862–872
Hendrix MJC, Seftor EA, Seftor REB et al (2007) Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7:246–255
Nishimura EK, Jordan SA, Oshima H et al (2002) Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416:854–860
Yu H, Fang D, Kumar SM et al (2006) Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol 168:1879–1888
Fang D, Nguyen TK, Leishear K et al (2005) Tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65:9328–9337
Bittner M, Meltzer P, Chen Y et al (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536–540
Schatton T, Murphy GF, Frank NY et al (2008) Identification of cells initiating human melanomas. Nature 451:345–358
Prehn RT (1982) Immunological surveillance versus immunological stimulation of oncogenesis — a formal proof of the stimulation hypothesis. Adv Exp Med Biol 155:77–85
Dahl C, Guldberg P (2007) The genome and epigenome of malignant melanoma. APMIS 115:1161–1176. Review
Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954
Rodolfo M, Daniotti M, Vallacchi V (2004) Genetic progression of metastatic melanoma. Cancer Lett 214:133–147. Review
Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184–192. Review
Chow LM, Baker SJ (2006) PTEN function in normal and neoplastic growth. Cancer Lett 241:184–196. Review
Isshiki K, Elder DE, Guerry D, Linnenbach AJ (1993) Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer 8:178–184
Segrelles C, Lu J, Hammann B et al (2007) Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res 67:10879–10888
Baril P, Gangeswaran R, Mahon PC et al (2007) Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 26:2082–2094
Hussussian CJ, Struewing JP, Goldstein AM et al (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15–21
Ehlers JP, Worley L, Onken MD, Harbour JW (2008) Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 14:115–122
Baggetto LG, Gambrelle J, Dayan G et al (2005) Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects. Cancer Treat Rev 31:361–379. Review
Niederkorn JY, Wang S (2005) Immunology of intraocular tumors. Ocul Immunol Inflamm 13:105–110
Mimeault M, Hauke R, Mehta PP, Batra SK (2007) Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11:981–1011
Simka M (2008) Do nonmelanoma skin cancers develop from extra-cutaneous stem cells? Int J Cancer Epub ahead of printing Jan 31
Labialle S, Dayan G, Gambrelle J et al (2005) Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives. Melanoma Res 15:257–266
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by an unrestricted educational grant from GlaxoSmithKline.
Both authors have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Belmar-Lopez, C., Mancheno-Corvo, P., Saornil, M.A. et al. Uveal vs. cutaneous melanoma. Origins and causes of the differences. Clin Transl Oncol 10, 137–142 (2008). https://doi.org/10.1007/s12094-008-0170-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0170-4